Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1977 Jun;4(3):321–326. doi: 10.1111/j.1365-2125.1977.tb00720.x

Digoxin measurements in general practice.

D W Holt, J D Williamson, G N Volans
PMCID: PMC1429082  PMID: 901700

Abstract

1 As part of a prospective study on the use of digoxin in a general practice, plasma digoxin concentrations were measured in all patients receiving the drug. 2 A low mean plasma digoxin concentration was observed, suggesting a cautious approach to digitalization. 3 The correlation between plasma digoxin concentration and signs or symptoms commonly used in the assessment of digoxin effect was poor. 4 It was concluded that the measurement of plasma digoxin could be of assistance in a variety of clinical settings within a general practice.

Full text

PDF
321

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beller G. A., Smith T. W., Abelmann W. H., Haber E., Hood W. B., Jr Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med. 1971 May 6;284(18):989–997. doi: 10.1056/NEJM197105062841801. [DOI] [PubMed] [Google Scholar]
  2. Carruthers S. G., Kelly J. G., McDevitt D. G. Plasma digoxin concentrations in patients on admission to hospital. Br Heart J. 1974 Jul;36(7):707–712. doi: 10.1136/hrt.36.7.707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Curtis P. Long-term digoxin treatment in general practice. Br Med J. 1975 Dec 27;4(5999):747–749. doi: 10.1136/bmj.4.5999.747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dall J. L. Maintenance digoxin in elderly patients. Br Med J. 1970 Jun 20;2(5711):705–706. doi: 10.1136/bmj.2.5711.705. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ewy G. A., Groves B. M., Ball M. F., Nimmo L., Jackson B., Marcus F. Digoxin metabolism in obesity. Circulation. 1971 Nov;44(5):810–814. doi: 10.1161/01.cir.44.5.810. [DOI] [PubMed] [Google Scholar]
  6. Fonrose H. A., Ahlbaum N., Bugatch E., Cohen M., Genovese C., Kelly J. The efficacy of digitalis withdrawal in an institutional aged population. J Am Geriatr Soc. 1974 May;22(5):208–211. doi: 10.1111/j.1532-5415.1974.tb01940.x. [DOI] [PubMed] [Google Scholar]
  7. Gregg I., Nunn A. J. Peak expiratory flow in normal subjects. Br Med J. 1973 Aug 4;3(5874):282–284. doi: 10.1136/bmj.3.5874.282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harding P. R., Aronow W. S., Eisenman J. Digitalis as an antianginal agent. Chest. 1973 Oct;64(4):439–443. doi: 10.1378/chest.64.4.439. [DOI] [PubMed] [Google Scholar]
  9. Heizer W. D., Smith T. W., Goldfinger S. E. Absorption of digoxin in patients with malabsorption syndromes. N Engl J Med. 1971 Jul 29;285(5):257–259. doi: 10.1056/NEJM197107292850504. [DOI] [PubMed] [Google Scholar]
  10. Holt D. W., Benstead J. G. Postmortem assay of digoxin by radioimmunoassay. J Clin Pathol. 1975 Jun;28(6):483–486. doi: 10.1136/jcp.28.6.483. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hurwitz N., Wade O. L. Intensive hospital monitoring of adverse reactions to drugs. Br Med J. 1969 Mar 1;1(5643):531–536. doi: 10.1136/bmj.1.5643.531. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Kirsten E., Rodstein M., Iuster Z. Digoxin in the aged. Geriatrics. 1973 Jan;28(1):95–101. [PubMed] [Google Scholar]
  13. Lindenbaum J., Mellow M. H., Blackstone M. O., Butler V. P., Jr Variation in biologic availability of digoxin from four preparations. N Engl J Med. 1971 Dec 9;285(24):1344–1347. doi: 10.1056/NEJM197112092852403. [DOI] [PubMed] [Google Scholar]
  14. Manninen V., Apajalahti A., Melin J., Karesoja M. Altered absorption of digoxin in patients given propantheline and metoclopramide. Lancet. 1973 Feb 24;1(7800):398–400. doi: 10.1016/s0140-6736(73)90252-3. [DOI] [PubMed] [Google Scholar]
  15. Marsh W. W., Perlman L. V. Understanding congestive heart failure and self-administration of digoxin. Geriatrics. 1972 Jul;27(7):65–70. [PubMed] [Google Scholar]
  17. Smith T. W., Butler V. P., Jr, Haber E. Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med. 1969 Nov 27;281(22):1212–1216. doi: 10.1056/NEJM196911272812203. [DOI] [PubMed] [Google Scholar]
  18. Smith T. W., Haber E. Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest. 1970 Dec;49(12):2377–2386. doi: 10.1172/JCI106457. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. VON CAPELLER D., COPELAND G. D., STERN T. N. Digitalis intoxication: a clinical report of 148 cases. Ann Intern Med. 1959 Apr;50(4):869–878. doi: 10.7326/0003-4819-50-4-869. [DOI] [PubMed] [Google Scholar]
  20. Wagner J. G., Yates J. D., Willis P. W., 3rd, Sakmar E., Stoll R. G. Correlation of plasma levels of digoxin in cardiac patients with dose and measures of renal function. Clin Pharmacol Ther. 1974 Mar;15(3):291–301. doi: 10.1002/cpt1974153291. [DOI] [PubMed] [Google Scholar]
  21. Weintraub M., Au W. Y., Lasagna L. Compliance as a determinant of serum digoxin concentration. JAMA. 1973 Apr 23;224(4):481–485. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES